Tego Science, Inc.
Develops and commercializes cell therapies for regenerative medicine.
191420 | KO
Overview
Corporate Details
- ISIN(s):
- KR7191420009
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강서구 마곡중앙8로 93 (마곡동, 테고사이언스), 서울특별시
- Website:
- http://www.tegoscience.com/
- Sector:
- Manufacturing
Description
Tego Science, Inc. is a biopharmaceutical company specializing in the development and commercialization of cell therapies for regenerative medicine. The company leverages proprietary, advanced cell culture technology for the mass production of human epithelial cells. Its portfolio of approved products includes Holoderm®, an autologous cultured epidermis for severe burns; Kaloderm®, an allogeneic cell therapy for burns and diabetic foot ulcers; and Rosmir®, an autologous fibroblast treatment for wrinkles. In addition to its therapeutic products, Tego Science provides Neoderm®, a 3D cultured skin model used as an alternative to animal testing, and offers CDMO services. The company's clinical pipeline features TPX-115, a first-in-class allogeneic fibroblast-based therapy for treating rotator cuff tears, currently in late-stage clinical trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-03-29 00:00 |
정기주주총회결과
|
Korean | 19.3 KB | ||
| 2021-03-19 00:00 |
감사보고서제출
|
Korean | 24.8 KB | ||
| 2021-03-19 00:00 |
사업보고서 (2020.12)
|
Korean | 1.1 MB | ||
| 2021-03-15 00:00 |
[기재정정]주주총회소집공고
|
Korean | 140.0 KB | ||
| 2021-03-15 00:00 |
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
|
Korean | 55.6 KB | ||
| 2021-03-12 00:00 |
주주총회소집결의
|
Korean | 8.9 KB | ||
| 2021-03-12 00:00 |
주주총회소집공고
|
Korean | 137.9 KB | ||
| 2021-02-09 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 10.9 KB | ||
| 2020-12-14 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2020-11-13 00:00 |
분기보고서 (2020.09)
|
Korean | 787.3 KB | ||
| 2020-11-13 00:00 |
[기재정정]분기보고서 (2020.09)
|
Korean | 789.9 KB | ||
| 2020-11-06 00:00 |
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 17.8 KB | ||
| 2020-10-19 00:00 |
기타경영사항(특허권취득)(자율공시)(진피층 및 표피층을 포함하는 삼차원 배양 피부모델을 제조하는 방법 및 이를 통해 제조된 삼차원 배양 피부모…
|
Korean | 5.7 KB | ||
| 2020-09-15 00:00 |
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
|
Korean | 31.6 KB | ||
| 2020-08-20 00:00 |
기업설명회(IR)개최
|
Korean | 7.3 KB |
Automate Your Workflow. Get a real-time feed of all Tego Science, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Tego Science, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Tego Science, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
